| 000 | 01384 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250514210829.0 | ||
| 264 | 0 | _c20050901 | |
| 008 | 200509s 0 0 spa d | ||
| 022 | _a0034-9887 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLópez, Mercedes | |
| 245 | 0 | 0 |
_a[Advances in cellular immunotherapy for malignant melanoma]. _h[electronic resource] |
| 260 |
_bRevista medica de Chile _cSep 2004 |
||
| 300 |
_a1115-26 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Clinical Trial, Phase I; English Abstract; Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 |
_aAntigens, Neoplasm _ximmunology |
| 650 | 0 | 4 |
_aCancer Vaccines _ximmunology |
| 650 | 0 | 4 |
_aDendritic Cells _ximmunology |
| 650 | 0 | 4 |
_aEnzyme-Linked Immunosorbent Assay _xmethods |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aHypersensitivity, Delayed |
| 650 | 0 | 4 |
_aImmunotherapy _xadverse effects |
| 650 | 0 | 4 |
_aInterleukin-2 _xadverse effects |
| 650 | 0 | 4 |
_aMelanoma _ximmunology |
| 650 | 0 | 4 | _aPulse Therapy, Drug |
| 650 | 0 | 4 |
_aSkin Neoplasms _ximmunology |
| 650 | 0 | 4 |
_aT-Lymphocytes, Cytotoxic _ximmunology |
| 700 | 1 | _aEscobar, Alejandro | |
| 700 | 1 | _aAlfaro, Jorge | |
| 700 | 1 | _aFodor, Miguel | |
| 700 | 1 | _aLarrondo, Milton | |
| 700 | 1 | _aFerrada, Carlos | |
| 700 | 1 | _aSalazar-Onfray, Flavio | |
| 773 | 0 |
_tRevista medica de Chile _gvol. 132 _gno. 9 _gp. 1115-26 |
|
| 999 |
_c15230507 _d15230507 |
||